Hossein Tavana

University of Akron

Papers

13

Total Citations

375

H-Index

9

About

Hossein Tavana is a biomedical engineer whose research sits at the intersection of cancer biology, drug discovery, and microtechnology. He is best known for pioneering aqueous two-phase systems (ATPS) as a platform for generating and manipulating three-dimensional tumor spheroids — miniature, physiologically relevant models of avascular tumors that more faithfully replicate the complexity of solid cancers than traditional flat cell cultures. Tavana's most influential contribution, published in 2014 and garnering 93 citations, introduced a high-throughput microprinting approach capable of producing tumor spheroids in standard 96-well plates using immiscible polymeric aqueous solutions. This innovation addressed a longstanding bottleneck in drug discovery by enabling reproducible, large-scale spheroid production compatible with automated screening workflows. Subsequent work expanded this platform to support multiparametric oncology drug screening, combination drug testing, and cancer cell migration assays, collectively accumulating hundreds of citations across the field. Beyond cancer pharmacology, Tavana has applied microprinting technology to stem cell biology, demonstrating that colony size meaningfully regulates neural differentiation — a finding with implications for regenerative medicine. His 2020 organotypic breast tumor model further advanced understanding of tumor microenvironment dynamics. Through elegant engineering solutions, Tavana has consistently translated fundamental biological questions into scalable, quantitative experimental platforms.

Research Focus

Key Achievements

9
H-Index
13
Papers
375
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
High Throughput, Polymeric Aqueous Two‐Phase Printing of Tumor Spheroids
93 citations · 2014
📈 Most Prolific Year: 2015 (4 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: University of Akron

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago